X-54810125-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_177433.3(MAGED2):c.449C>A(p.Ala150Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000416 in 1,201,594 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 12 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_177433.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAGED2 | NM_177433.3 | c.449C>A | p.Ala150Glu | missense_variant | 3/13 | ENST00000375068.6 | NP_803182.1 | |
MAGED2 | NM_014599.6 | c.449C>A | p.Ala150Glu | missense_variant | 3/13 | NP_055414.2 | ||
MAGED2 | NM_201222.3 | c.449C>A | p.Ala150Glu | missense_variant | 3/13 | NP_957516.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAGED2 | ENST00000375068.6 | c.449C>A | p.Ala150Glu | missense_variant | 3/13 | 1 | NM_177433.3 | ENSP00000364209 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000448 AC: 5AN: 111565Hom.: 0 Cov.: 23 AF XY: 0.0000890 AC XY: 3AN XY: 33723
GnomAD3 exomes AF: 0.000246 AC: 41AN: 166652Hom.: 0 AF XY: 0.000127 AC XY: 7AN XY: 55026
GnomAD4 exome AF: 0.0000413 AC: 45AN: 1090029Hom.: 0 Cov.: 31 AF XY: 0.0000253 AC XY: 9AN XY: 356197
GnomAD4 genome AF: 0.0000448 AC: 5AN: 111565Hom.: 0 Cov.: 23 AF XY: 0.0000890 AC XY: 3AN XY: 33723
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 15, 2021 | The c.449C>A (p.A150E) alteration is located in exon 3 (coding exon 2) of the MAGED2 gene. This alteration results from a C to A substitution at nucleotide position 449, causing the alanine (A) at amino acid position 150 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
MAGED2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 09, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at